- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06565312
A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.
August 20, 2024 updated by: Love Wellness
This is a virtual single-group clinical trial lasting 8 weeks to evaluate the effects of a probiotic vaginal suppository on vaginal health.
Participants will use the Flora Power suppository daily for 5 consecutive days when experiencing common signs of vaginal imbalance.
They will complete questionnaires and vaginal pH tests before and after product use.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Female at birth, aged 18+.
- Interested in maintaining a healthy vaginal environment.
- Experience common signs of vaginal imbalance (e.g., malodor, irritation).
- Willing to avoid other vaginal products and follow study protocol.
Exclusion Criteria:
- Recent surgeries or invasive treatments.
- Use of vaginal health products in the last 12 weeks.
- Allergies to product ingredients.
- Chronic health conditions impacting participation.
- Pregnant, breastfeeding, or trying to conceive.
- History of substance abuse or smoking.
- Currently participating in another clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Flora Power Probiotic Vaginal Suppository
Participants will use the Flora Power suppository once daily at bedtime for 5 consecutive days when they feel they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/or vaginal itching.
|
The suppository contains Microcrystalline Cellulose, Ascorbic Acid, Vitamin C, Gelatin Capsule, Vaginal Probiotic Blend (Lactobacillus fermentum LF61, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90), Magnesium Stearate, and Silicon Dioxide.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect on Vaginal pH and Health
Time Frame: Baseline, Day 6 (24 hours after the last suppository insertion)
|
Measure the change in vaginal pH levels with a test strip from baseline to 24 hours after the 5-day intervention period.
|
Baseline, Day 6 (24 hours after the last suppository insertion)
|
|
Effect on Vaginal pH and Health
Time Frame: Baseline, Day 6 (24 hours after the last suppository insertion)
|
Measure the change in overall vaginal health from baseline to 24 hours after the 5-day intervention period with a questionnaire.
|
Baseline, Day 6 (24 hours after the last suppository insertion)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Perception of Vaginal Freshness and Odor
Time Frame: Baseline, Day 2, Day 5
|
Evaluate participants' perceptions of the vaginal suppository's impact on vaginal freshness and odor, as well as the support of a calm, soothed, and balanced vaginal environment.
This outcome measure is assessed with questionnaires.
|
Baseline, Day 2, Day 5
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2024
Primary Completion (Actual)
July 10, 2024
Study Completion (Actual)
July 10, 2024
Study Registration Dates
First Submitted
July 11, 2024
First Submitted That Met QC Criteria
August 20, 2024
First Posted (Actual)
August 21, 2024
Study Record Updates
Last Update Posted (Actual)
August 21, 2024
Last Update Submitted That Met QC Criteria
August 20, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20434
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Health
-
Love WellnessCitruslabsCompletedVaginal Health | Vaginal pHUnited States
-
Love WellnessCitruslabsCompletedWomen's Health | Vaginal HealthUnited States
-
Radicle ScienceActive, not recruitingVaginal HealthUnited States
-
UAS Labs LLCCompleted
-
Lesaffre InternationalBiofortis Mérieux NutriscienceCompleted
-
Ocean Spray Cranberries, Inc.RecruitingGut Microbiome | Vaginal Microbiome | Gut HealthUnited States
-
Gynuity Health ProjectsUniversity of California, Los Angeles; University of Illinois at Chicago; Oregon... and other collaboratorsCompleted
-
University of Castilla-La ManchaActive, not recruitingSexual Dysfunction | Vaginal Health | Genitourinary Syndrome of MenopauseSpain
-
Garden of Life, LLCValidcare, LLCActive, not recruitingVaginal HealthUnited States
-
RaelCitruslabsCompletedIrritable Bowel Syndrome | Vaginal HealthUnited States
Clinical Trials on Flora Power Probiotic Vaginal Suppository
-
Kevin HellmanNot yet recruiting
-
Hadassah Medical OrganizationActive, not recruiting
-
University of New MexicoWithdrawnInterstitial Cystitis | Bladder Pain SyndromeUnited States
-
Padagis LLCCompleted
-
Seed HealthCompletedVaginal Personal CareUnited States
-
Hatem AbuHashimUnknownVulvovaginal Candidiasis
-
Taiwan Carbon Nano Technology CorporationAinos, Inc. (f/k/a Amarillo Biosciences Inc.RecruitingVaginitis | Vaginal InfectionTaiwan
-
Amplexd Therapeutics, Inc.Chinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong KongRecruitingASC-US | Uterine Cervical Dysplasia | HPV Infection | Cervical Abnormalities | High-risk HPV (Any Strain) | LSIL, Low Grade Squamous Intraepithelial LesionHong Kong
-
Renew Life Formulas IncSprim Advanced Life SciencesUnknown
-
Cairo UniversityCompleted